Document |
Document Title |
WO/2019/085682A1 |
The present invention relates to an organometallic complex luminescent material, having a structural formula of formula (I), wherein A, B, and C are independently a substituted or an unsubstituted C, N, O, or S atom; and the dotted ring ...
|
WO/2019/088281A1 |
[Problem] The purpose of the present invention is to provide an organic compound for use as a material in a highly efficient and highly durable organic electroluminescent element, said compound exhibiting superior hole injection and tran...
|
WO/2019/084696A1 |
Compounds are described and characterized that bind guanine quadruplexes of DNA or RNA. Binding data and inhibition of growth data of five cancer cell lines are presented.
|
WO/2019/083514A1 |
An example of a fusing agent includes a metal bis(dithiolene) salt, a polar aprotic solvent, and a balance of water. An example of a method for making an example of the fusing agent includes adding a metal bis(dithiolene) salt into a liq...
|
WO/2019/078715A1 |
The present invention relates to a compound of the formula (l): [Z-L]MQn (l) wherein Z represents a metal cation selected from the group consisting of palladium, platinum or gold or mixtures thereof; L is a tetradentate polypyridyl ligan...
|
WO/2019/071102A1 |
A method for forming polar-functionalized polyolefins may comprise contacting an unsubstituted α-olefin monomer and an amino-olefin monomer of formula H2C=CH(CH2)n(CHR)mNR'2, wherein R is H or an unsubstituted linear or branched alkyl g...
|
WO/2019/065448A1 |
A cobalt complex represented by formula (1), which exhibits excellent catalytic activity in hydrosilylation reactions and is excellent in terms of handleability and solubility in silicones. {In formula (1), R1 to R3 each independently re...
|
WO/2019/066729A1 |
Disclosed herein is a compound of formula (I): [M(L)n]m+ (Ay-)z (I) wherein M represents Ru, Fe, Co, Rh, Ir, Ni, Os, Cr, Cu or Mn; A represents an anionic group having a charge y, wherein y is 1 to 4, m is 1 to 4, n is 2 to 6, z is 1 to ...
|
WO/2019/063353A1 |
The present invention relates to an activator composition comprising a) between 0.5% and 50% by weight of a catalyst K for crosslinking two-component adhesives which is liquid at 23°C, b) between 40% and 99.5% by weight of an organic so...
|
WO/2019/065388A1 |
Provided is a composition containing a metal complex represented by formula (1) and a metal complex represented by formula (2). In formula (1), M1 represents an iridium or the like; n1 represents an integer of 1 or more; n2 represents an...
|
WO/2019/067635A1 |
The disclosure provides methods for sequencing nucleic acids using, including with nucleotide analogs and subsequently appended labels.
|
WO/2019/066179A1 |
The present invention relates to a vapor deposition compound capable of thin film deposition through vapor deposition and, specifically, to nickel and cobalt precursors capable of being applied to atomic layer deposition (ALD) or chemica...
|
WO/2019/056515A1 |
A multi-substituted quinolone-coordinated iridium-hybridized compound and a preparation method therefor, as well as an application of the compound in electroluminescent materials. Ligand modification of the compound comprises second posi...
|
WO/2019/057050A1 |
The present invention relates to the technical field of porous composite material preparation, and provides a slurry synthesis method for a porous composite framework material. A mass ratio of a solvent to a solid reactant is controlled,...
|
WO/2019/053312A1 |
The present invention belongs to the field of electrocatalysts, more specifically to the field of electrocatalysts derived from metal-organic frameworks. In particular, the present invention relates to a iron zeolitic imidazolate framewo...
|
WO/2019/051246A1 |
Use of (pyrophosphato)platinum(II) or platinum(IV) complexes ("phosphaplatins"), especially l,2-cyclohexanediamine(pyrophosphato) platinum(II), as immunogenic cell death (ICD) inducing agents and their combination with immune checkpoint ...
|
WO/2019/032241A1 |
The present disclosure generally relates to metal-organic framework nanoparticles containing terminal phosphate-modified oligonucleotides, methods for making the same, and methods of using the same.
|
WO/2019/030304A1 |
The invention relates to ylide-functionalised phosphane ligands, the production of same and use in transition metal compounds, as well as the use of same as catalysts in organic reactions.
|
WO/2019/029789A1 |
New improved fluorinated metal complexes based on bi pyridine ligands are disclosed. The complexes are characterized by a balance of fluorination among specific substituents attached to the pyridine rings, i.e. the overall number of fluo...
|
WO/2019/030117A1 |
To provide a film forming material and a film forming process for forming, at a lower temperature, a Ge-containing Co film including a desired amount of Ge. A film forming material for forming a Ge-containing Co film according to the inv...
|
WO/2019/025575A1 |
There is provided herein a process for the preparation of a complex of formula (I): Rh(II)2 Xn, wherein X and n have meanings provided in the description, comprising the step of reacting: (a) a source of Rh(III); and (b) a source of X, w...
|
WO/2019/024169A1 |
Disclosed in the invention are a water-soluble IDO (dioxygenase) inhibitor cisplatin and a preparation method and application thereof. The water-soluble IDO inhibitor cisplatin medicine synthesized with the preparation method of the pres...
|
WO/2019/021836A1 |
The present invention relates to a vapor deposition raw material for manufacturing a platinum thin film or a platinum-compound thin film by a vapor deposition method. This vapor deposition raw material comprises an organoplatinum compoun...
|
WO/2019/020538A1 |
The invention relates to iridium complexes that are suitable for use in organic electroluminescent devices, in particular as emitters.
|
WO/2019/018464A1 |
A platinum organosiloxane complex is prepared by a process including 1) combining A) a platinous halide and B) a ketone, and thereafter 2) adding C) a polyorganosiloxane having, per molecule, 2 to 4 silicon bonded terminally unsaturated ...
|
WO/2019/018773A1 |
Method of making a cross metathesis product, the method comprising at least step (X) or step (Y): (X) reacting in a cross metathesis reaction a first compound comprising a terminal olefinic group with a second compound comprising a termi...
|
WO/2019/018357A1 |
A catalyst having a specific structure and a method fop rearing the catalyst is disclosed. A composition is also disclosed, which comprises: (A) an unsaturated compound including at least one aliphatically unsaturated group per molecule,...
|
WO/2019/018461A1 |
A platinum organosiloxane complex is prepared by a process including combining A) a platinous halide; B) a ketone; C) an enone additive distinct from any other starting materials or rearrangement products thereof; and D) a polyorganosilo...
|
WO/2019/018735A1 |
Provided herein are photochemical separations. The methods herein can include exposing a first metal complex and a second metal complex to light to facilitate an irreversible chemical reaction to form a modified first metal complex. The ...
|
WO/2019/008279A1 |
The invention relates to the use of iron compounds as catalysts for hydrosilylation and/or dehydrogenative silylation.
|
WO/2019/008308A1 |
There is described a method for preparation of an imaging medium via transfer from a hyperpolarised singlet state that is not parahydrogen, said method comprising the steps of: (i) preparing a system containing: parahydrogen; a magnetisa...
|
WO/2019/001754A1 |
The invention relates to a composition that can be used as a catalyst in hydrosilylation, comprising at least one platinum compound selected from the group consisting of Pt[(Me2SiCH=CH2)2O]2 and Pt2[(Me2SiCH=CH2)2O]3 and at least one rho...
|
WO/2018/236199A1 |
The present invention relates to a ligand for forming a copper complex, a ligand for forming a palladium complex, a copper complex catalyst, a palladium complex catalyst, a production method therefor and a use thereof.
|
WO/2018/236237A1 |
The present invention relates to the preparation of nove1 nickel complexes containing iminopyrrolyl-type ligands, having the general molecular structure (I), and to their use as active catalysts in the polymerisation reaction of ethylene...
|
WO/2018/233273A1 |
Provided is an industrial preparation method for a high-purity dicycloplatin needle-like crystal, comprising: mixing and reacting carboplatin, 1,1-cyclobutane dicarboxylic acid and water, and crystallizing same to obtain a dicycloplatin ...
|
WO/2018/236191A1 |
The present invention relates to a novel ligand for forming a ruthenium complex, a ruthenium complex catalyst, a production method therefor and a use thereof. The ligand for forming a ruthenium complex and the ruthenium complex catalyst,...
|
WO/2018/226682A1 |
Optionally substituted BODIPY-Iridium complexes, such as those depicted Formula 4, may be useful in filters for display devices.
|
WO/2018/225466A1 |
Provided are: a curing accelerator for an oxidatively polymerized unsaturated resin, having high curing acceleration characteristics; and a printing ink and paint using same. Specifically, provided are: a curing accelerator for an oxidat...
|
WO/2018/062758A9 |
The present disclosure relates to an organic electroluminescent material comprising at least two types of compounds and an organic electroluminescent device comprising the same. The organic electroluminescent device having better color p...
|
WO/2018/217998A1 |
A composition is disclosed. The composition comprises: (A) an unsaturated compound including at least one aliphatically unsaturated group per molecule, subject to at least one of the following two provisos: (1) the (A) unsaturated compou...
|
WO/2018/214932A1 |
Small molecule compounds having aggregation-induced emission (AIE) characteristics. The compounds include organic, aromatic salts having anion-π+ interactions. In some embodiments, the anion-π+ interactions can include heavy-atom-anion...
|
WO/2018/210631A1 |
The present invention refers to a process for a Rh-catalyzed Anti-Markovnikov hydrocyanation of terminal alkynes which process discloses, for the first time, the highly stereo- and regio-selective hydrocyanation of terminal alkynes to fu...
|
WO/2018/212251A1 |
Provided is an iridium complex represented by general formula (1) having a phenyltriazole ligand that presents an emission spectrum that has a narrow half-value width in the visible light region (especially the blue region). (In general ...
|
WO/2018/210616A1 |
The invention relates to a process for producing (4-halogeno-2,6-dialkylphenyl)malononitriles of formula (I) by reaction of bromoaromatics of formula (II) with malononitrile in the presence of a base, a palladium compound and a phosphine...
|
WO/2018/198975A1 |
Provided is a light-emitting element having excellent luminance life. Disclosed is a light-emitting element comprising a positive electrode, a negative electrode, a first organic layer provided between the positive electrode and the nega...
|
WO/2018/197963A1 |
The invention relates to a method for the preparation of cyclic compounds in the metathesis of olefins from acyclic dienes comprising terminal and/or non-terminal C=C double bonds; the invention also relates to the use of homogeneous rut...
|
WO/2018/198971A1 |
Provided is a composition useful for manufacturing a light-emitting element having excellent light-emitting efficiency. A composition containing a phosphorescent compound represented by formula (1) and a compound represented by formula (...
|
WO/2018/198974A1 |
Provided is a light-emitting element having excellent luminance life. This light-emitting element comprises: a positive electrode; a negative electrode; and a first organic layer and a second organic layer provided between the positive e...
|
WO/2018/199283A1 |
A composition containing a compound represented by formula (H-1) and a phosphorescent compound, wherein the amount of a compound that is contained as an impurity in said composition, and that has a molecular weight that is greater by 16 ...
|
WO/2018/198972A1 |
Provided is a composition useful for manufacturing a light-emitting element having excellent luminance life. The composition comprises a compound represented by formula (C-1), a metal complex represented by formula (1), and a metal compl...
|